RPRX · CIK 0001802768 · operating
Royalty Pharma plc (RPRX) is a pharmaceutical preparations company incorporated in United Kingdom, listed on the Nasdaq. With a market capitalization of $27.5 billion, Royalty Pharma plc is a large-cap company. The stock currently trades at $47.47, up 2.73% today, with a 52-week range of $29.66–$47.50. The company trades at a trailing P/E of 26.7x and a forward P/E of 8.7x. Royalty Pharma plc pays an annual dividend yield of 1.90%.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $1.78 | $1.79 | -6.8% | |
| 2024 | $1.91 | $1.92 | -24.5% | |
| 2023 | $2.53 | $2.54 | +2430.0% | |
| 2022 | $0.10 | $0.10 | -93.3% | |
| 2021 | $1.49 | $1.49 | +12.9% | |
| 2020 | $1.32 | $1.32 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-11 | 0001802768-26-000003 | SEC ↗ |
| 2024-12-31 | 2025-02-12 | 0001802768-25-000010 | SEC ↗ |
| 2023-12-31 | 2024-02-15 | 0001802768-24-000012 | SEC ↗ |
| 2022-12-31 | 2023-02-15 | 0001802768-23-000007 | SEC ↗ |
| 2021-12-31 | 2022-02-15 | 0001802768-22-000011 | SEC ↗ |
| 2020-12-31 | 2021-02-24 | 0001802768-21-000006 | SEC ↗ |